<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>14(3)</volume><submitter>Bhattacharyya S</submitter><pubmed_abstract>Gallic acid (GA) is well known for its antioxidant and hepatoprotective activity, though its effectiveness is restricted due to rapid metabolism and elimination. To overcome these problems, gallic acid-phospholipid complex was prepared and the effect of phospholipid complexation was investigated on carbon tetrachloride (CCl4)-induced oxidative damage in rat liver. The complex significantly reduced the hepatic marker enzymes in rat serum and restored the antioxidant enzyme levels with respect to CCl4-induced group (P &lt; 0.05 and P &lt; 0.01). Also, the complex improved the pharmacokinetics of GA by increasing the relative bioavailability and elimination half-life. The study therefore suggests that phospholipid complexation has enhanced the therapeutic efficacy of GA which may be due to its improved absorption and increased bioavailability in rat serum.</pubmed_abstract><journal>AAPS PharmSciTech</journal><pagination>1025-33</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3755146</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>The gallic acid-phospholipid complex improved the antioxidant potential of gallic acid by enhancing its bioavailability.</pubmed_title><pmcid>PMC3755146</pmcid><pubmed_authors>Mukherjee PK</pubmed_authors><pubmed_authors>Bhattacharyya S</pubmed_authors><pubmed_authors>Saha BP</pubmed_authors><pubmed_authors>Ahammed SM</pubmed_authors></additional><is_claimable>false</is_claimable><name>The gallic acid-phospholipid complex improved the antioxidant potential of gallic acid by enhancing its bioavailability.</name><description>Gallic acid (GA) is well known for its antioxidant and hepatoprotective activity, though its effectiveness is restricted due to rapid metabolism and elimination. To overcome these problems, gallic acid-phospholipid complex was prepared and the effect of phospholipid complexation was investigated on carbon tetrachloride (CCl4)-induced oxidative damage in rat liver. The complex significantly reduced the hepatic marker enzymes in rat serum and restored the antioxidant enzyme levels with respect to CCl4-induced group (P &lt; 0.05 and P &lt; 0.01). Also, the complex improved the pharmacokinetics of GA by increasing the relative bioavailability and elimination half-life. The study therefore suggests that phospholipid complexation has enhanced the therapeutic efficacy of GA which may be due to its improved absorption and increased bioavailability in rat serum.</description><dates><release>2013-01-01T00:00:00Z</release><publication>2013 Sep</publication><modification>2025-04-04T23:24:24.5Z</modification><creation>2019-03-27T01:15:10Z</creation></dates><accession>S-EPMC3755146</accession><cross_references><pubmed>23800857</pubmed><doi>10.1208/s12249-013-9991-8</doi></cross_references></HashMap>